The Oncodarwinian Hypothesis (OdH) proposes a paradigm shift: cancer is not merely a disease but a potential macro‑immunoadaptive response – a self‑replicating algorithm that can be reprogrammed via ...

Sanyou Bio today announced the launch of SAI-DA 1.0 (Sanyou AI-Drug Accelerator). The platform builds on the company's AI-STAL (AI Super-Trillion Antibody Library), which serves as a vast molecular ...

Miovision today introduced the world's first GenAI-informed, end-to-end traffic signal optimization and retiming solution on Miovision One, giving cities and transportation agencies a faster, more ...

Introduction - Your latest trial sponsor is using AI to accelerate protocol development and patient recruitment,[1] cutting ...

Scientists in China used computer analyses to identify two genes driving pulmonary arterial hypertension that may prove a ...

As generative intelligence optimizes facial features, the line between digital perfection and surgical reality fades into ...

MIT and Mecalux unveil GENESIS, an AI-powered simulator optimizing inventory and logistics, reducing costs, enhancing supply ...

Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.

Learn how AI medical discovery is bridging the gap between lab research and bedside treatments, resulting in faster and more ...

Most genetic studies focus on people from European ancestry. But Africa has the richest diversity and must be included in ...

Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies.

Researchers develop an interpretable hybrid feature selection model to overcome the "curse of dimensionality"in genomic ...